US Hospital Care for Patients with HIV Infection and Pneumonia: The Role of Public, Private, and Veterans Affairs Hospitals in the Early Highly Active Antiretroviral Therapy Era

Chest

Volumn 125, Issue 2, 2004, Pages 548-556

  Uphold, Constance R ^a,f   Deloria Knoll, Maria ^b   Palella Jr , Frank J ^b   Parada, Jorge P ^c,d   Chmiel, Joan S ^b   Phan, Laura ^e   Bennett, Charles L ^e  

^a N FL/S Georgia Vet Health System   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d HINES VA HOSPITAL   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f Research Department   (United States)

Author keywords

Community acquired pneumonia; HIV; Pneumocystis cariini pneumonia; Quality of care

Indexed keywords

ANTIBIOTIC AGENT; ANTIPROTOZOAL AGENT; ANTIRETROVIRUS AGENT; CORTICOSTEROID;

ADD ON THERAPY; ADULT; AIDS RELATED COMPLEX; ARTICLE; ARTIFICIAL VENTILATION; COMMUNICABLE DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST; EPIDEMIOLOGY; FEMALE; GOVERNMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL CARE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METHODOLOGY; MORTALITY; NONPARAMETRIC TEST; PATIENT CARE; PATIENT COMPLIANCE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PRIVATE HOSPITAL; PROBABILITY; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SAMPLE SIZE; STANDARD; TREATMENT OUTCOME; UNITED STATES; UTILIZATION REVIEW;

EID: 1242351694     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.2.548     Document Type: Article

References (31)

1. Bennett CL, Curtis JR, Achenbach C, et al. U. S. hospital care for HIV-infected persons and the role of public, private, and Veterans Administration hospitals. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:416-421
2. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-860
3. Sepkowitz KA. AIDS: the first 20 years. N Engl J Med 2001; 344:1764-1772
4. Bozzette SA, Joyce G, McCaffrey DF, et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. N Engl J Med 2001; 344:817-823
5. Arno PS, Gourevitch MN, Drucker E, et al. Analysis of a population based Pneumocystis carinii pneumonia index as an outcome measure of access and quality of care for the treatment of HIV disease. Am J Public Health 2002; 92:395-398
6. Afessa B, Green B. Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest 2000; 117:1017-1022
7. Bartlett JG. Pneumonia in the patient with HIV infection. Infect Dis Clin North Am 1998; 12:807-820
8. Wolff AJ, O'Connell AE. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy. Chest 2001; 120:1888-1893
9. Arozullah AM, Yarnold PR, Weinstein RA, et al. A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am J Respir Crit Care Med 2000; 161:1-6
10. Oken C, Archibald N, Cvitanic M, et al. Multi-city study of quality of care for HIV-related Pneumocystis carinii pneumonia: successfully collecting highly sensitive information. Clin Perform Qual Health Care 1995; 3:140-146
11. American Hospital Association guide to the health care field. Chicago, IL: American Hospital Association, 2001/2002
12. Arozullah AM, Parada J, Bennett CL, et al. A rapid preadmission staging system for predicting inpatient mortality among HIV patients with community-acquired pneumonia. Chest 2003; 123:1151-1160
13. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250
14. Park DR, Sherbin VL, Goodman MS, et al. The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness. J Infect Dis 2001; 184:268-277
15. Miller R, Millar AB, Weller IVD, et al. Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. JAMA 1989; 44: 559-564
16. Pozniak A, Tung KT, Swinburn CR, et al. Clinical and bronchoscopic diagnosis of suspected pneumonia related to AIDS. BMJ 1986; 293:797-799
17. Tu JV, Biem HJ, Detsky AS. Bronchoscopy versus empirical therapy in HIV-infected patients with presumptive Pneumocystis carinii pneumonia: a decision analysis. Am Rev Respir Dis 1993; 148:370-377
18. The National Institutes of Health-University of California Expert Panel for Corticosteroid as Adjunctive Therapy for Pneumocystis Pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in AIDS. N Engl J Med 1990; 323:1500-1504
19. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus: Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995; 333:845-851
20. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-1754
21. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31:347-382
22. Englert J, Davis KM, Koch KE. Using clinical practice analysis to improve care. Jt Comm J Qual Improv 2001; 27:291-301
23. Metersky ML, Galusha DH, Meehan TP. Improving the care of patients with community-acquired pneumonia: a multihospital collaborative QI project. Jt Comm J Qual Improv 1999; 25:182-190
24. Kaboli PJ, Barnett MJ, Fuehrer SM, et al. Length of stay as a source of bias in comparing performance in VA and private sector facilities: lessons learned from a regional evaluation of intensive care outcomes. Med Care 2001; 39:1014-1024
25. Ritchie JL, Maynard C, Chapko MK, et al. A comparison of percutaneous transluminal coronary angioplasty in the Department of Veterans Affairs and in the private sector in the state of Washington. Am J Cardiol 1998; 81:1094-1099
26. Thomas JW, Bates EW, Hofer T, et al. Interpreting risk-adjusted length of stay patterns for VA hospitals. Med Care 1998; 36:1660-1675
27. Cegielski JP, Goetz MB, Jacobson JM, et al. Gender differences in early suspicion of tuberculosis in hospitalized, high-risk patients during 4 epidemic years, 1987 to 1990. Infect Control Hosp Epidemiol 1997; 18:237-243
28. Bennett CL, Schwartz D, Lane DR, et al. Variations in inpatient care for HIV-related tuberculosis patients during a recent nosocomial outbreak of multidrug-resistant tuberculosis. J Acquir Immune Defic Syndr 1999; 21:348-349
29. Bennett CL, Garfinkle JB, Greenfield S, et al. The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP. JAMA 1989; 261:2975-2979
30. Bennett CL, Adams J, Gertler P, et al. Relation between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: experience from 3, 126 cases in New York City in 1987. J Acquir Immune Defic Syndr 1992; 5:856-864
31. Mathews W, Ferdon E, Bennett CL, et al. Evaluating institutional performance in AIDS-associated Pneumocystis carinii pneumonia: a risk-adjustment model. J Clin Epidemiol 1989; 42:421-425